Practical recommendations for the management of diabetes in patients with COVID-19

Stefan R. Bornstein*, Francesco Rubino, Kamlesh Khunti, Geltrude Mingrone, David Hopkins, Andreas L. Birkenfeld, Bernhard Boehm, Stephanie Amiel, Richard IG Holt, Jay S. Skyler, J. Hans DeVries, Eric Renard, Robert H. Eckel, Paul Zimmet, Kurt George Alberti, Josep Vidal, Bruno Geloneze, Juliana C. Chan, Linong Ji, Barbara Ludwig

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

616 Citations (Scopus)


Diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus 2. Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20–50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic. We aim to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.

Original languageEnglish
Pages (from-to)546-550
Number of pages5
JournalThe Lancet Diabetes and Endocrinology
Issue number6
Early online date23 May 2020
Publication statusPublished - Jun 2020


Dive into the research topics of 'Practical recommendations for the management of diabetes in patients with COVID-19'. Together they form a unique fingerprint.

Cite this